Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2025
Myeloid-derived suppressor cell-targeted virus-like particles synergistically activate innate immune response for cancer immunotherapyZhixiong Zhu, Shuqin Cao, Hanwen Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 16, 2024
mRNA-Engineered CD5-CAR-γδTCD5- Cells for the Immunotherapy of T-Cell Acute Lymphoblastic LeukemiaZhixiong Zhu, Hexian Li, Qizhong Lu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 9, 2026
A macrophage-targeted bivalent saRNA vaccine protects against ocular and cutaneous HSV-1 infection in miceYanfang Li, Zongliang Zhang, Zhixiong Zhu, et al.
Translational Oncology|April 17, 2020
Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell LymphomaMeijun Zheng, Lingyu Yu, Juanjuan Hu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 20, 2022
Lipid Nanoparticle Delivery System for mRNA Encoding B7H3-redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant TumorsCheng Huang, Xing Duan, Jichao Wang, et al.
Molecular and Cellular Biochemistry|April 8, 2025
TOR1 AIP1 interacts with p53 to enhance cell cycle dysregulation in prostate cancer progressionZhaofeng Li, Xueyu Li, Han Yang, et al.
Biomolecules|December 23, 2022
Evaluation of B7-H3 Targeted Immunotherapy in a 3D Organoid Model of CraniopharyngiomaMei Tang, Caili Chen, Guoqing Wang, et al.
Journal for Immunotherapy of Cancer|February 18, 2026
YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myelomaJia Li, Qizhong Lu, Zhixiong Zhu, et al.
Cell Death & Disease|July 12, 2025
CENPT prevents renal cell carcinoma against ferroptosis by enhancing the synthesis of glutathioneHan Yang, Zongliang Zhang, Ninghan Feng, et al.
Pageof 10